| :: ym biosciences inc |
Seite 95 der Diskussion 'YMI in this stock? oder YM Biosciences die MISSISSAUGA, ON -- YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM),
YM Biosciences Shareholder Update. 23 March 2011. This is an occasional update of some of the important news about YM BioSciences Inc. As you are aware,
YM BioSciences Inc. Announces Orphan Drug Designation For JAK1/JAK2 YM BioSciences Inc. Announces Exercise Of Full Over-Allotment Option For Total
Results 1 - 28 The article reports on YM BioSciences Inc., a Mississauga, Ontario-based company. YM BioSciences is in a Phase 3 trial of its breast-cancer
YM BioSciences Inc. completes recruitment for tesmilifene pilot Phase II trial in prostate cancer; 70% response rate reported. Posted September
YM BioSciences Inc. is a drug development company. It is currently advancing three clinical stage products: CYT387, a small molecule, dual
March 14th, 2011 we released our published article: "TooNiceStocks Initiates Coverage on YM Biosciences Inc. Digging Deeper into the Bullish
As at April 30, the Company had 116467644 shares outstanding. About YM BioSciences YM BioSciences Inc. is a drug development company advancing.
MISSISSAUGA, Canada I December 12, 2011 I M BioSciences Inc. (NYSE Amex: YMI, TSX: YM), today reported updated results from the
YM BIOSCIENCES INC (FQA:GR) stock price & investing information. Find YM BIOSCIENCES INC historical stock quotes, key competitors, stock data,
This page contains information about YM BioSciences Inc.(YM)
Ym Biosciences Inc. Stock Price (YMI) Stock Quote and real time streaming Ym Biosciences - Stock Charts, - Company Information, News, Level 2 Data,
YM BioSciences Inc. Mergers and Acquisitions Snapshot, M&A Deals Timeline, Stakes, Divestitures.
Legal Name: YM BioSciences Inc. Operating Name: YM BioSciences Inc. Mailing Address 400-5045 Orbitor Dr Bldg 11. MISSISSAUGA
YM BioSciences Inc. (Ontario, Mississauga) YM BioSciences Inc. (Ontario, Mississauga). YM BioSciences Inc. 5045 Orbitor Drive Building 11, Suite 400
Register now for FREE live YM BioSciences Inc share prices, YM BioSciences Inc stock quotes, charts, trades and FREE YM BioSciences Inc company
menafn: YM BioSciences Inc's net loss narrowsCAD0.9m for first quarter fiscal 2012Nov 14, 2011 (M2 EQUITYBITES via COMTEX) --Drug
Breaking news, pictures, videos and more from around world the about YM BioSciences, Inc..
YM BioSciences, Inc. Class Action lawsuit news, YM BioSciences, Inc. class action lawsuit information, and links to YM BioSciences, Inc. news and stock price
Thomas Allen, Counsel, Ym Biosciences Inc. of Ym Biosciences Inc.''s information - including email, business address, business phone, biography, title,
YM BioSciences Inc. - Product Pipeline Review - H2 2011 YM BioSciences Inc. - Product Pipeline Review - H2 2011 Summary Global Market.
FREE Canadian stocks dividend data and tools with DividendInvestors.ca. Find the most updated Ym Biosciences Inc YM Canadian stocks dividend data on the
YM BioSciences Inc. is advancing two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor
View iStockAnalyst's scorecard for YM BioSciences, Inc.(YMI). Learn more about investing into YMI from the industry experts. Track YMI sentiment survey and
This one was brought to my attention by a buddy of mine. I know nothing about it other than it just got some news about approval of marketed a
We are reiterating our BUY rating on YM BioSciences, Inc. (NYSE AMEX: . 2 YM Biosciences Inc. press release, “YM Biosciences Announces
Correspondence: David G.P. Allan, Chairman, Chief Executive Officer, YM BioSciences Inc., 5045 Orbitor Drive, Building 11, Suite 400,. Mississauga, Ontario
MISSISSAUGA, ON, March 28 /PRNewswire-FirstCall/ -- YM BioSciences Inc. , the cancer product development company, today announced
This was a T! call friday afternoon - I added. PR in the AH friday night Ym Biosciences Announces Results of Randomized Nimotuzumab Study
YM BioSciences Inc. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share YM BioSciences Inc. | NYSE Amex Equities: YMI | NYSE
YM BioSciences Inc. (USA) (NYSEAMEX:YMI) is a drug development company advancing a diverse portfolio of hematology and cancer-related
YM BioSciences Inc. (YMI), At 4:00PM EST: 1.63 Down 0.03 (1.81%) send us feedback. Message Boards Settings YM BioSciences Inc.
YM BioSciences, Inc., an Ontario based drug development company advancing a diverse portfolio of hematology and cancer-related products,
YM BioSciences Inc. (AMEX: YMI) Digging Deeper into the Bullish Sentiment and TooNiceStocks research has unveiled YM Biosciences Inc. has been the
20 PRNewswire - YM BioSciences Inc. (NYSE Amex YMI, TSX YM), a life sciences product development company advancing a diverse portfolio
Vien Brewster, Controller, Ym Biosciences Inc. of Ym Biosciences Inc.''s information - including email, business address, business phone, biography, title,
View the basic YM.TO stock chart on Yahoo! Finance. Change the date range, chart type and compare YM BIOSCIENCES INC against other companies.
T.YM YM BioSciences Inc. Inter-Citic Minerals Inc. | T.ICI. 10/1/2010. Focus Metals Inc.- Plans over the next 2-5 yrs. Focus Metals Inc. | V.FMS. 11/25/2010
Get detailed financial information on YM BioSciences Inc. (USA) (NYSEAMEX: YMI) including real-time stock quotes, historical charts & financial news, all for
Digging Deeper into the Bullish Sentiment and Upcoming Catalyst in Early June 2011 Why YM BioSciences Inc. will continue its uptrend?
Free article about 'YM BioSciences Inc and Therapure Biopharma Inc announce contract. Therapure Biopharma to perform.
YMI - YM BioSciences Inc. (YMI) Stock Research Analysis - YM BioSciences Inc. ( YMI) Stock Research Analysis, Stock News, Stock Profile, Stock Summary,
YM BioSciences Inc. Company Research (YMI) Share Prices, Charts, News, Financials, and More - Digital Look.
YM BioSciences' detailed financials; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma industry
Stock quote for YM BioSciences, Inc. (YMI) - Get real-time last sale and extended hours stock prices, company news, charts, and
YM BioSciences Inc. Therapeutic Competitor Report contains detailed information on pipelines by phase and therapeutic indication as well as management
Home › YM Biosciences Inc Kontanten AB · Bessemer Venture Partners investment in Cerulean Pharma Inc (103917) · Craig Heim employment at Wisconsin
12, 2011 /PRNewswire/ - YM BioSciences Inc. (YMI), today reported updated results from the ongoing Phase I/II study of its JAK1/JAK2 inhibitor, CYT387.
YM Biosciences Aktie (WKN 911799 / ISIN CA9842381050) - Aktueller Kurs, Charts Wertpapier: YM Biosciences Inc. Registered Shares o.N.
Wiki coverage on YM BIOSCIENCES INC, including quotes, charts, news, analyst research, historical returns, message boards, due diligence, fundamentals,
In early 2010, the Melbourne based operations of Cytopia Ltd were merged with Canadian based YM BioSciences Inc. The product portfolio of Cytopia, built
Ym Biosciences Inc in Mississauga with phone number, address, and interactive map. Call Ym Biosciences Inc now free of charge or write a review.
On December 17, 2010, YM BioSciences Inc. (AMEX: YMI; TSX:YM) (“YM BioSciences” or the “Company”) closed a $40 million public offering of 25000000
YM BioSciences, Inc. is a drug development company that is engaged in the Gilbert Wenzel, 54 Director, Ym Biosciences, Inc., Venus Remedies Ltd.
YM BioSciences Inc. announces it has closed its previously announced “ registered YM BioSciences Inc. and Therapure Biopharma Inc. announce contract
YM BioSciences Inc. is a company that identifies, develops and commercializes differentiated products principally in the area of oncology for patients worldwide.
17 /PRNewswire-FirstCall/ - David Allan , Chairman and CEO of YM BioSciences Inc. and Thomas Wellner , President and CEO of Therapure Biopharma Inc.
12, 2011 (CRWENEWSWIRE) - YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), today reported updated results from the ongoing Phase I/II
Date, File Type, % Own, Filer/Issuer, Subject Company, Ticker
EV/EBITDA ratio of YM Biosciences Inc (US Listing) (CA9842381050 - YM) and its peer group for financial analysis.
YM BioSciences Inc. (AMEX:YMI) is up 10.96% in midday trading at $1.62. YMI has traded 5.6 million shares so far today, 5 times its daily
YM BioSciences Inc., today reported preclinical results for its JAK1/JAK2 inhibitor CYT387 in multiple myeloma (MM), published in the advance
Cytopia Merger with Toronto-based YM BioSciences Inc.
YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse
Instant ALOETTE COSMETICS INC versus YM BIOSCIENCES INC Stock Quotes. Analyze ALOETTE COSMETICS INC versus YM BIOSCIENCES INC Shares.
Insider trading report for Ym Biosciences, Inc YMI stock. See insider buying and selling for last 24 months.
YM BioSciences Inc. Bldg 11, 400-5045 Orbitor Dr Mississauga, ON L4W 4Y4 Tel : (905) 629-9761. Fax: (905) 629-4959. Contact Name James Smith. Industry
Rimon Therapeutics Ltd., Ontario. Stem Cell Therapeutics Corp., Alberta. StemPath Inc., Ontario. Variation Biotechnologies Inc., Quebec. YM BioSciences Inc.
Get the latest stock quote and more - DailyFinance is your source for YM BioSciences, Inc. (USA) stock price. Interactive Data Managed
Hoover's offers YM BioSciences Inc. information and related Biopharmaceuticals & Biotherapeutics facts online.
Detailed Share Price, Charts and News for YM Biosciences Inc [TSE,YM]. Share Market Tools for Successful Investing. Global Share Market
Do not invest in Ym Biosciences, Inc (YMI) stock before you read this free research report on the company.
Credit & Investment Research, Thomson StreetEvents: YM BioSciences Inc. Conference Call & Analyst Meeting to discuss the interim results
YM BIOSCIENCES INC COM NPV Toronto: YM.TO,TSE:YM technical analysis and research for investors, will it rise or fall?, come and read
S, 2008-02-14 09:49:12, YM BIOSCIENCES INC · n/a · Xmark Opportunity Partners, 1.7%, view. B, 2007-12-20 16:21:25, YM BIOSCIENCES INC · n/a
BioWorld Online is the news service of record for the biotechnology industry and is updated every business morning. BioWorld Online will keep you up to date
Results 1 - 20 of 253 6-K, YM BIOSCIENCES INC, 11/23/11 (11/22/11). 6-K, YM BIOSCIENCES INC, 11/14/11 (09/30/11). 6-K, YM BIOSCIENCES INC, 11/14/11
American BioSciences, Inc - Nature and Science for Better Health. American . a b "Company Profile for YM BioSciences inc (CA;YM)". Retrieved on
InsideStocks is the leading provider of intraday stock and commodities realtime or delayed charts with powerful indicators and technical analysis. Search for
MISSISAUGA, ON, Oct. 31, 2011 /PRNewswire/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM) today announced that preliminary results of a Phase II study
YM BioSciences Inc. (AMEX: YMI) is a drug development company. It is currently advancing three clinical stage products: CYT387, a small
YM Biosciences Inc is a biopharmaceutical company engaged in the development of products for the treatment of cancer or cancer-related conditions.
YMI - Short squeeze stock short interest data and short selling information for shares of Ym Biosciences Inc. Short interest stock data available
YM BioSciences Inc. (AMEX:YMI), announced preclinical results for JAK1/JAK2 inhibitor CYT387 in multiple myeloma (MM), published in the
Company profile for YM BioSciences Inc. in Mississauga,ON. Get accurate business information including key contacts, company financials and more in the YM
The YM BioSciences Inc. (USA) (YMI) Competitors by Product report shows YM The report then maps YM BioSciences Inc. (USA) competing products to the
Get the latest YMI - YM Biosciences Inc. stock rating, stock market performance data and financial news.
Comprehensive and timely details of regulatory and non regulatory announcements from FTSE 100, 250, AIM and techMARK quoted companies.
Get detailed financial information on YM BioSciences USA Inc. () including real- time stock quotes, historical charts & financial news, all for free!
Results 1 - 20 of 344 6-K, YM BIOSCIENCES INC, 12/12/11 (12/12/11). 6-K, YM BIOSCIENCES INC, 11/23/11 (11/22/11). 6-K, YM BIOSCIENCES INC, 11/14/11
YM BioSciences Inc. (AMEX:YMI) is up 27.40% in pre market trading at $1.86. YMI has YM BioSciences has a market cap of 170.40 million.
Ym Biosciences Inc at 5045 Orbitor Dr, Mississauga, ON L4W 4Y4.
YM BioSciences Inc. (YM.TO) principally develops cancer therapeutics. It partners with biotechnology and pharmaceutical companies as well as with drug
Press Release Source: YM BioSciences Inc. On Tuesday March 30, 2010, 7:30 am EDT MISSISSAUGA, ON, March 30 /PRNewswire-FirstCall/
YM BioSciences, Inc.Get latest news on YM BioSciences, Inc., from firstpost and other sources worldwide. Photos, Articles, Stories, Quotes, Images and more on
YM BioSciences Inc. is a drug development company advancing three products: CYT387, a small molecule, dual inhibitor of the JAK1/JAK2
This release is a result of our current concentration on YM BioSciences Inc. ( AMEX:YMI)(TSX:YM) and their latest corporate developments and
YM BioSciences Inc. is a cancer drug development company. It licenses research products from academic institutions and other biotechnology companies which
Ym Biosciences Inc. (AMEX:YMI): On 06/30/2011, Discovery Capital Management reported holding 2327650 shares with a market value of
YM BioSciences Inc.-Deals & Alliances Report, YM BioSciences Inc.-Deals & Alliances ReportReport contains the company's contact information, business
YM BioSciences Inc. (USA) NYSEAMEX:YMI recently reported operational and financial results for its first quarter of fiscal 2012, ended
About YM BioSciences. YM BioSciences Inc. is a life sciences product development company. Together with the products from YM BioSciences
YM BioSciences Inc. (USA) (NYSEAMEX:YMI) witnessed volume of 3.70 million shares during last trade however it holds an average trading
Stock analysis for YM:CN. Get stock price, historical stock charts & news for YM Biosciences Inc, in the Therapeutics industry.
10 /CNW/ - YM BioSciences Inc. (AMEX: AIM:YMBA), the cancer product development company, announced to entered into an exclusive worldwide license
An opioid formulation for pulmonary administration in the treatment or management of pain, a pulmonary drug delivery device containing,
11, 2011 /CNW/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a drug development company advancing a diverse portfolio of hematology
YM Biosciences Inc. | 905-629-9761 | 905-629-4959 | 5045 Orbitor Dr, Suite 400, Mississauga, ON.
MISSISSAUGA, ON, Apr. 26, 2010 (Canada NewsWire Group) -- /CNW/ -- YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), announced today that it has filed a
YMI - YM BioSciences Inc - SocialPicks. Form 6-K YM BIOSCIENCES INC For: Sep 29. Graphic_arrow1 YM BioSciences licensee Pulmokine
YM BIOSCIENCES INCSEC FILINGS. View all filings and insider trading for YM BIOSCIENCES INC.
YM BioSciences Inc. YMI (ASE). Help. Real-time prices for U.S.-listed stocks, including premarket and after hours, reflect trading through Nasdaq only.
Ym Biosciences USA Inc company profile in Chesterbrook, PA. Our free company profile report for Ym Biosciences USA Inc includes business information such
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM) today announced results of a collaboration with researchers at the University of Toronto for the
MISSISSAUGA, ON, July 31 /PRNewswire-FirstCall/ - YM BioSciences Inc. , a company engaged in the acquisition, development and
Goliath's Ym Biosciences Inc. Company Profile provides detailed company information on Ym Biosciences Inc. located in Mississauga, CANON
7, 2011 /PRNewswire/ - YM Biosciences Inc . (NYSE Amex: YMI, TSX: YM), today announced it would report updated results from its Phase I/II
Analysis of YMI, YM BIOSCIENCES INC in American and Canadian Stock Markets NYSE, NASDAQ, AMEX, OTC, TSX,and CDNX, End-of-Day Stock Data, Alert
YM BioSciences Inc. YMI (ASE). AD: Find a Broker; Help. Real-time prices for U.S.-listed stocks, including premarket and after hours, reflect trading through
YM BioSciences Inc. (YM) is a drug development company advancing a diverse portfolio of hematology and cancer-related products.
Insider Overview :: YM BioSciences Inc. (T:YM), [?] Latest 10 SEDI filings (by transaction date) for YM within the last 6 months, [?] Amended
YM BioSciences Inc. (NYSE:YMI), reported updated results from the ongoing Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the
The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2012. All rights
Ym Biosciences Inc - 6-K - For 12/3/04 - EX-99.1 - Report of a Foreign Private Issuer - Seq. 2 - Exhibit 99.1 Ym Biosciences Adopts
Why YM BioSciences Inc. will continue its uptrend?
YM BioSciences Provides Update on the Development Program for Nimotuzumab- Eleven abstracts on nimotuzumab to be presented at ASCO
Latest Pulse Events on YM BioSciences Inc. by Reni Benjamin of Rodman & Renshaw, Josh Schimmer of Leerink Swann & Company, Eben Tessari of
Develops cancer therapeutics, mainly through partnerships and joint ventures. Lists products and their development phases, news, corporate and financial
YM BioSciences Inc: The first stock on the list is biopharmaceutical company YM BioSciences Inc. (AMEX: YMI), which develops products for
YM BioSciences, Inc. (NYSE AMEX: YMI, TSX: YM) is a life-sciences We are reiterating our BUY rating on YM BioSciences, Inc. (NYSE
Get YMI stock quote information for YM Biosciences Inc, including a stock overview, one-click scorecard, industry position, and the latest headlines.
YM BioSciences Inc. (YM) is a drug development company advancing a diverse portfolio of hematology and cancer-related products. The Company is advancing
CYT387: Potent Dual Inhibitor of JAK 1/2 in Phase I/II Clinical Development (YM BioSciences Inc.) ymbiosciences. Subscribe Subscribed
JAK1/2 inhibitor currently in Phase II clinical study in myelofibrosis- MISSISSAUGA, ON, Aug. 10 /CNW/ - YM BioSciences Inc. (NYSE Amex:YMI, TSX :YM),
YM BioSciences Inc. (AMEX: YMI) develops, markets, and commercializes hematology and cancer-related products in the drug development
YM BioSciences Inc. is a drug development company advancing three clinical- stage products: CYT387, a small molecule, dual inhibitor of
About YM BioSciences YM BioSciences Inc. is a life sciences product development company that identifies and advances a diverse portfolio of promising
We are reiterating our BUY rating on YM BioSciences, Inc. (NYSE April 21, 2010, YM BioSciences, Inc. announced data for CYT387 in the
YM BioSciences Inc. (AMEX:YMI) announced its JAK1/JAK2 inhibitor, CYT387 has received positive opinions from the Committee for Orphan
Delex Therapeutics, Inc. (Acquired by YM BioSciences, Inc.) About Us YM BioSciences is a life sciences product development company that identifies and
4, 2011 /PRNewswire/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), today reported preclinical results for its JAK1/JAK2 inhibitor CYT387
YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer-related products, today reported
YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. The Company is
Find financial news for YM BioSciences Inc. (USA) (NYSEAMEX:YMI) using Google Finance.
YM BIOSCIENCES INC is traded at AMEX. YM BIOSCIENCES INC is a part of the Drug Manufacturers - Other industry, inside the Healthcare sector, it has NaN
What stock price is YMI? Get the latest news and information about YM BioSciences Inc. in real-time. Find out what professional investors, analysts, and hedge
Ym Biosciences, Inc. (YMI) rated Mkt Outperform with price target $4 by Rodman & Renshaw - GainersToday. See more Stock market
YM BioSciences is a bio-pharmaceutical company which is evaluating lead compound nimotuzumab (nimo) (an IgG1, humanized epidermal
YMI Stock HQ. In-depth research & opinions on YM BioSciences Inc. (YMI) from expert traders and investors who follow YMI closely.
Equities research analysts at Collins Stewart initiated coverage on shares of YM BioSciences Inc. (NYSE: YMI) in a research note to investors
Baxter International Inc. and Synovis Life Technologies, Inc. announced today a definitive agreement for YM BioSciences, Inc. (AMEX:YMI)
12, 2011 /PRNewswire/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), today reported updated results from the ongoing Phase I/II study of
YM BioSciences Reports Updated Phase I/II Data For Its JAK1/JAK2 Inhibitor CYT387 At ASH 2011 - PR Refresh Stock Quote for YM Biosciences Inc. - YMI
22, 2011 /CNW/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), today YM BioSciences Inc. is a drug development company advancing
MISSISSAUGA, ON, June 3 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), today announced the appointment of Dr.
Hoovers company profile of YM BioSciences Inc.. Find detailed business information such as key executives, financials and other corporate data on YM
About YM BioSciences Inc., YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients
'ym biosciences inc' related content. Editorial content matching 'ym biosciences inc'. Content with tags matching 'ym biosciences inc':
In our complete report available for purchase the company is compared to: Ondine Biomedical Incorporated, YM Biosciences Inc and Isotechnika Pharma
YM YM BioSciences Inc. Focus Metals Inc.- Plans over the next 2-5 yrs . YM BioSciences Reports Updated Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387
FE Investegate announcements from YM BioSciences Inc., Research Update.
YM BioSciences Inc. (NYSE:YMI) is a drug development company advancing a portfolio of hematology and cancer-related products.
YM BioSciences, Inc. (USA) (AMEX:YMI). + Watch YMI. on My Watchlist. $1.67 0.01 (+0.60%). 1/11/2012 4:00 PM
4, 2011 /PRNewswire/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM BioSciences Inc. is a drug development company advancing three
ASX Circular. Page 1 of 2. No: 009/10. CYTOPIA LIMITED - MERGER WITH YM BIOSCIENCES. INC. BY SCHEME OF ARRANGEMENT
Health care industry insiders provide analysis & data on pharma biotech device & diagnostic company strategy & trends. Deals & technology
Results 1 - 7 of 9 About Company: YM Biosciences Inc. is developing cancer drugs based on technologies licensed primarily from international academic centers
FE Investegate announcements from YM BioSciences Inc., Directorate Change.
Now Available: YM BioSciences Inc. (YM) - Financial and Strategic Analysis Review.
YM BioSciences Inc.(AMEX:YMI, TSX:YM, AIM:YMBA), a company engaged in the acquisition,development and commercialization of oncology
YM BioSciences Inc. - Product Pipeline Review - H2 2011 Summary Global Market Direct's pharmaceuticals report,
YM BioSciences Inc. is a life sciences product development company advancing a diverse YM BioSciences is currently advancing three late-stage products:
Preview the profile for YM BIOSCIENCES INC Agreements. Docstoc is a community for people to find and share professional documents.
View the basic YMI stock chart on Yahoo! Finance. Change the date range, chart type and compare YM BioSciences, Inc. Ordinary S against other companies.
Stock market news and stock research. Financial news, stock news and stock makrket update about the stocks, ETF and mutual funds listed on the NYSE, AMEX
YM BioSciences Inc.-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in
Market valuation multiples for YM Biosciences Inc (US Listing) (CA9842381050 - YM) compared to its main competitors.
Instant YM BIOSCIENCES INC (YMI) Stock Analysis. How To Buy, Sell, and Trade YMI Online. Stock Price, Quotes, and Dividends!
Get SEC filings for YM Biosciences, Inc. (YMI), including Annual Report (10k) and Quarterly Report (10Q).
YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), reported preclinical results for its JAK1/JAK2 inhibitor CYT387 in multiple myeloma (MM),
Throughout the day, 25.37 million shares of Alcoa Inc. exchanged hands as compared to its YM BioSciences Inc. (USA) (AMEX:YMI):
ASX Circular. Page 1 of 1. No: CYTOPIA LIMITED - MERGER WITH YM BIOSCIENCES INC. BY. SCHEME OF ARRANGEMENT. Participating
YM BioSciences Inc. (USA) (NYSEAMEX:YMI) witnessed volume of 3.62 million shares during last trade however it holds an average trading
Shared by: YM BIOSCIENCES INC Agreements. Categories Managements Discussion And Analysis - YM BIOSCIENCES INC - 9-23-2011
Insider Trading. News. Log In; Sign Up. Main · Insider Purchases · Insider Sales · Browse Companies · Home > Insider Trading > Y M Biosciences Inc > Profile
2012-01-08 YMI: Ym Biosciences Inc Institutional Investments! Ym Biosciences Inc sold some -239367 shares, change of -32.50% to total position of $879943
Stock analysis for FQA:GR. Get stock price, historical stock charts & news for YM Biosciences Inc, in the Therapeutics industry.
YM BioSciences Inc. Global Public & Private Company Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as
Ym Biosciences, Inc. (YMI) rated Buy with price target $6 by Roth Capital - GainersToday. See more Stock market recommendations, Upgrades
YM BIOSCIENCES INC. Patent applications. Patent application number, Title, Published. 20100189778, OPIOID DELIVERY SYSTEM - An opioid formulation for
17 /PRNewswire-FirstCall/ -- YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM, AIM:YMBA), a life sciences product development company that
EV / Revenue Use Average, YM YM BioSciences Inc. DNA Genentech, Inc. Change, AMGN Amgen, Inc. Change, GILD Gilead Sciences, Inc. Change, CELG
YMI - YM BioSciences Inc - SocialPicks. Form 6-K YM BIOSCIENCES INC For: Sep 29. Graphic_arrow1 YM BioSciences licensee Pulmokine awarded NIH
YM BioSciences Inc. (USA) (NYSEAMEX:YMI) is a drug development company advancing a diverse portfolio of hematology and cancer-related products.
Drug (brand / generic) Tesmilifene; Company / licensee YM BioSciences Inc; Therapy class Chemopotentiator; Product description Small molecule which boosts
YM Biosciences Inc. stock price today: (YMI) stock quote, price history, earnings per share, technical analysis chart and breaking news.
YM BioSciences Inc (AMEX:YMI) is a Canadian company that seeks to treat cancer and cancer-related afflictions through the continued
YM Biosciences Inc is a biopharmaceutical company engaged in the development of products for the treatment of cancer or cancer-related
YM Biosciences, Inc. About Us YM BioSciences Inc., a Canadian company incorporated in 1994, principally develops cancer therapeutics. It partners with
YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), announced that the merger of Cytopia Limited, the Australian biopharmaceutical company,
YM BioSciences Inc.-Detailed Product Pipeline, published March 2011, pages 174, YM BioSciences Inc.-Detailed Product Pipeline provides up to date insight
YM Biosciences Inc share price (). View the share price, trading information for YM Biosciences Inc and other shares. Hargreaves Lansdown gives you free
26, 2011 /PRNewswire/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a drug development company advancing a diverse portfolio of
Get company or corporate stock equity shareholder selling or sales data for shares of YM Biosciences, Inc. including Fund and Institutional shareholders.
Stock analysis for YMI:US. Get stock price, historical stock charts & news for YM Biosciences Inc, in the Therapeutics industry.
YM BioSciences Inc. Unauthorized recording or downloading of this event is not permitted.
See how the ZeccoShare Community is trading YM Biosciences Inc (YMI)at Zecco. Get hot tips, picks, predictions and more.
YM BioSciences Inc.-Therapeutic Competitors Report YM BioSciences Inc.- Therapeutic Competitors Report Report includes a business
Ibex Technologies Inc. operates in the Medicinals and botanicals sector. Therapeutics, Inc., Thallion Pharmaceuticals Incorporated and YM Biosciences Inc.
YM BioSciences Inc. - Product Pipeline Review - H2 2011 - new company profile.
YM BioSciences Inc.-Therapeutic Competitors Report, published March 2011, pages 198, YM BioSciences Inc.-Therapeutic Competitors Report Report includes
Ms. Shulze was CEO of YM Biosciences US and President, YM Biosciences, Inc., a global biopharmaceutical organization. Prior to joining YM Biosciences in
Poster with broader update of trial results to be presented at ASCO - YM BioSciences Inc., today reported updated interim results for the first 60 patients with
Shares of YM BioSciences Inc. (AMEX: YMI), a drug development company advancing a diverse portfolio of hematology and cancer-related
Browse CNBC and partner stories, analysis, blogs and video catagorized by topic or author.
424B3: YM BIOSCIENCES INC. - Find EDGAR Online-Prospectus and Proxies articles.
Therapure Biopharma to perform fill/finish of nimotuzumab - MISSISSAUGA ON Dec. 17 / David Allan ChairmaNimotuzumab is a humanized
The Center of molecular immunology with YM Biosciences and its licensees are Other licensees for nimotuzumab include Biocon BioPharmaceuticals Ltd.
United States YM BioSciences USA Inc. P.O. Box 21747. Lehigh Valley ,
YM BioSciences Inc. (NYSE: YMI) is a drug development company advancing a portfolio of hematology and cancer-related products. more Post a comment
YM BioSciences Inc. | +1-(905)-629-9761 | E-mail/RFQ, Address, Website, Profile , Reviews, Directions & Nearby Search.
YM BioSciences Inc. Cancer drug Development Company, includes tesmilifene, a small molecule chemopotentiator (for taxanes and anthracyclines).
YM BioSciences Inc. (USA) (NYSEAMEX:YMI) witnessed volume of 7.57 million shares during last trade however it holds an average trading
Find out the latest news headlines for YM BioSciences, Inc. Ordinary S (YMI).
YM BioSciences Inc. (NYSE: YMI) reported updated results from the ongoing Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the
YM BioSciences Inc. Stock Message Board, YMI Stock Quote, YMI Stock Chart, YMI Stock News.
26, 2011 /CNW/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a drug development company advancing a diverse portfolio of hematology
YM Biosciences, Inc. (YMI) Stock picks and trading strategies.
Up to date analysis of YM BioSciences Inc. (YMI) and its stock by hedge fund managers and industry experts. Find out what YM BioSciences Inc. is saying about
Description: YM BioSciences Inc. is a drug development company advancing a diverse portfolio of promising hematology and cancer-related products.
Ym Biosciences Inc is a Canada company in 5045 Orbitor Dr, Mississauga, ON L4W, Canada, belongs to PHARMACEUTICAL PRODUCTS WHOLESALE
MISSISSAUGA, Ont. - YM BioSciences Inc. (TSX:YM) posted a $31.2-million annual loss for fiscal 2011 as the drug development company's
YM BioSciences Inc. - ym. YM BioSciences Inc. ym go to snapshot add to favorites. post. see all posts, Overall Quality 2+, Overall Quality 3+, Overall Quality 4+
YM BioSciences Inc. (YMI) announced on Monday that preliminary results of a Phase II study evaluating the safety and efficacy of nimotuzumab
"YM BioSciences Inc.-Detailed Product Pipeline" was published on Thursday the 6th of January 2011 by Life Science Analytics. It is available
YM BioSciences Inc., a Canadian company incorporated in 1994, principally develops cancer therapeutics. It partners with biotechnology and
YM BioSciences Inc. Message board - Online Community of active, educated investors researching and discussing YM BioSciences Inc. Stocks.
22, 2011 /CNW/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), today reported that, in view of the unusual market activity in the common
"YM BioSciences Inc.-Therapeutic Competitors Report" was published on Thursday the 6th of January 2011 by Life Science Analytics.
Gary Floyd, YM BioSciences Inc., Berwyn, PA - Business Contact Information in Jigsaw's business directory. Jigsaw's business directory provides complete
FE Investegate announcements from YM BioSciences Inc., Regulatory Approval.
Get detailed financial information on YM BioSciences Inc. (TSE:YM) including real-time stock quotes, historical charts & financial news, all for free!
Research about YM BIOSCIENCES INC., including news, information, and reports with HighBeam Business : Arrive Prepared.
YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), today announced it would report updated results from its Phase I/II myelofibrosis study of CYT387,
Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization,
YM BioSciences Inc. (YM BioSciences) is a publicly held Canada-based company. The company is principally engaged in the development of products for the
YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a life sciences company developing a diverse portfolio of promising hematology and
YM BIOSCIENCES INC (YM:CN) stock price & investing information. Find YM BIOSCIENCES INC historical stock quotes, key competitors, stock data, executives
Contact Information. YM BioSciences Inc. 5045 Orbitor Dr., Bldg. 11, Ste. 400. Mississauga, Ontario L4W 4Y4, Canada Tel. 905-6299761. Fax 905-6294959
Mississauga, Ontario, Canada - YM BioSciences Inc. ("YM" or the "Company"), the international cancer drug development company, today announces its
YM BioSciences Inc. financial and business news, updates, and information from The New York Times and other leading providers.
Get YM BioSciences Inc. business contacts for Healthcare,
YM Biosciences Inc. microsite contains Pharmaceuticals BioPharma information on product specifications, white papers, and company information. Compare YM
YM BioSciences Inc. · Mississauga, ON Canada(NYSE Amex: YMI). Buy a report on 15 executives listed for YM BioSciences Inc.'s Mississauga, ON location.
US:YMI - Get Stock quote detail for YM BioSciences Inc. Stock quotes include the latest US:YMI market price and fundamental investing data, price charts.
YM BioSciences Inc. (AMEX:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients
Realtimekurs YM BioSciences, Inc. in Euro. Realtime Bid: 1,27 / Ask: 1,30. Datum : 10.01.2012 19:58:16. powered by Börse Stuttgart · Realtimekurs Popup öffnen
Share price chart for YM Biosciences, Inc.-YMI from Morningstar. Chart with index and company comparisons for YM Biosciences, Inc.-YMI.
YMI has a P&P score of 5/5 stars, with 29 Buy ratings to 9 Sell ratings.
Dr. Nick Glover, Ph.D., is the President, Chief Executive Officer, Director of YM BioSciences Inc. Dr. Glover is the President and Chief Executive Officer of the
Many YM BioSciences Inc. products on Amazon and other vendors for best prices !
Name: